Y.S.P. Southeast Asia Holding

YSPSAH

MYL7178OO006

Pharmaceuticals

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
2.98 ^MYR	-1.00%		+14.62%	+29.57%

May. 23	YSP Southeast Asia's Q1 Profit Rises on Improved Revenue	MT
May. 21	Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

August 23, 2022 at 08:55 am EDT

Y.S.P. Southeast Asia Holding Berhad reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was MYR 77.11 million compared to MYR 65.36 million a year ago. Net income was MYR 11.08 million compared to MYR 4.46 million a year ago. Basic earnings per share from continuing operations was MYR 0.0786 compared to MYR 0.0319 a year ago. Diluted earnings per share from continuing operations was MYR 0.0785 compared to MYR 0.0319 a year ago.
For the six months, sales was MYR 158.64 million compared to MYR 136.56 million a year ago. Net income was MYR 17.59 million compared to MYR 7.25 million a year ago. Basic earnings per share from continuing operations was MYR 0.1248 compared to MYR 0.0519 a year ago. Diluted earnings per share from continuing operations was MYR 0.1247 compared to MYR 0.0518 a year ago.

Latest news about Y.S.P. Southeast Asia Holding

YSP Southeast Asia's Q1 Profit Rises on Improved Revenue	May. 23	MT
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 21	CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Special Dividend for the Financial Year Ended 31 December 2023, Payable on 22 July 2024	Apr. 22	CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Ordinary Dividend for the Financial Year Ended 31 December 2023, Payable on 22 Jul 2024	Apr. 22	CI
Y.S.P. Southeast Asia Holding Bhd. Proposes First and Final Single-Tier Ordinary Dividend in Respect of Financial Year Ended 31 December 2023	Mar. 20	CI
Y.S.P. Southeast Asia Holding Bhd. Proposes Special Dividend in Respect of Financial Year Ended 31 December 2023	Mar. 20	CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27	CI
YSP Southeast Asia's Profit Plunges in Q3	Nov. 22	MT
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 21	CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI
Y.S.P. Southeast Asia Holding Berhad Announces Appointment of Mr. Lee Sen Huei as Independent and Non Executive Director	23-06-01	CI
Y.S.P. Southeast Asia Holding Berhad Announces Retirement of Dr. Lee Fang Chuan @ Lee Fang Chen as Non Independent and Non Executive Director	23-05-23	CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-23	CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Special Dividend for the Financial Year Ended December 31, 2022, Payable on 25, 2023	23-04-25	CI
Y.S.P. Southeast Asia Holding Berhad Announces Final Single-Tier Ordinary Dividend for the Financial Year Ended December 31, 2022, Payable on July 25, 2023	23-04-25	CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Director	23-03-31	CI
Y.S.P. Southeast Asia Holding Berhad Announces Re-Designation of Yau Teck Kong to Independent and Non Executive Chairman of Nomination Committee	23-03-31	CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Member of Remuneration Committee	23-03-31	CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Chairman of Nomination Committee	23-03-31	CI
Y.S.P. Southeast Asia Holding Berhad Announces Resignation of Tu Shu Yao as Independent and Non Executive Member of Audit Committee	23-03-31	CI
Y.S.P. Southeast Asia Holding Berhad Proposes Special Dividend for the Financial Year Ended 31 December 2022	23-03-20	CI
Y.S.P. Southeast Asia Holding Berhad Proposes First and Final Single-Tier Ordinary Dividend for the Financial Year Ended 31 December 2022	23-03-20	CI
Y.S.P. Southeast Asia Holding Berhad Appoints Puan Hasnah Binti Ismail as Independent and Non Executive Member of Remuneration Committee	23-03-20	CI
Y.S.P. Southeast Asia Holding Berhad Announces Datuk Dr. Anis Re-Designated from Chairman/Independent Director to Chairman/Non Independent and Non Executive Director	23-03-20	CI
Y.S.P. Southeast Asia Holding Berhad Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI

Chart Y.S.P. Southeast Asia Holding

Duration

Period

More charts

Company Profile

Y.S.P. Southeast Asia Holding Berhad is a Malaysia-based pharmaceutical company. The Company provides a range of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products. The Company's segments include Manufacturing, Trading and Investment holding. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products. The Trading segment is involved in the import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Company is engaged in investment holding and provision of management services. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., which provides management services in respect of product registration, trademark registration and national marketing and trading in all kinds of pharmaceutical products, and Alpha Active Industries Sdn. Bhd., which is engaged in the manufacturing of biotechnology products and health products.

Sector

Pharmaceuticals

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
Y.S.P. SOUTHEAST ASIA HOLDING	+29.57%	90.07M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+17.43%	42.25B
OTSUKA HOLDINGS CO., LTD.	+15.37%	21.27B
SANDOZ GROUP AG	+19.73%	15.23B
CIPLA LIMITED	+19.84%	14.36B
ZYDUS LIFESCIENCES LIMITED	+51.59%	12.74B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.40%	6.61B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.28%	5.66B